• Kimball Electronics outlined a sharpened strategy focused on higher-complexity electronics manufacturing, with increased emphasis on medical programs such as drug delivery.
• Fiscal 2026 outlook reaffirmed for net sales of $1.4 billion to $1.46 billion, adjusted operating income of 4.2% to 4.5% of net sales.
• Capital spending forecast at $50 million to $60 million, including about $30 million tied to a new Indianapolis facility that doubles its footprint for medical products.
• Fiscal 2025 revenue reported at $1.49 billion, with 77% of sales tied to customers with relationships of 10 years or more.
• Short-term liquidity cited at $358.5 million as of March 31, 2026, with total debt levels down 49% from peak.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kimball Electronics Inc. published the original content used to generate this news brief on May 18, 2026, and is solely responsible for the information contained therein.